蛋白质组学对表观遗传药物发现的贡献
Roberta Noberini1, Tiziana Bonaldi1,2
1Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Proteomics
|September 20, 2023
概括
基于质谱的蛋白质组学通过识别标和监测疗效来帮助表观遗传药物发现. 这项技术支持开发用于与表观遗传改变有关的疾病的新疗法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 像基因组修饰和DNA甲基化等表观遗传特征可以调节基因表达和细胞表型,而不会改变DNA序列.
- 表观遗传过程的失调与各种疾病有关,特别是癌症,推动了针对性治疗的需求.
- 表观遗传药物发现侧重于向参与修改或阅读表观遗传标记的蛋白质.
研究的目的:
- 在表观遗传药物发现中提供基于质谱 (MS) 的蛋白质组学应用的概述.
- 描述基于MS的蛋白质组学方法,支持药物发现管道.
- 突出基于MS的蛋白质组在开发和表观遗传药物的表征中的作用.
主要方法:
- 基于质谱 (MS) 的蛋白质组学.
- 对基因素翻译后修改的分析.
- 基因甲基化概况.DNA甲基化概况.
- 核位定位研究.核位定位研究.
主要成果:
- 基于MS的蛋白质组学是用于表观遗传药物发现的多功能工具.
- 它有助于目标验证,目标解卷和监测药物疗效.
- 特定的MS方法支持药物发现管道的各个阶段.
结论:
- 基于MS的蛋白质组学对于推动表观遗传药物发现至关重要.
- 它有助于识别和描述新的表观遗传药物标和疗法.
- 这项技术在开发治疗表观遗传相关疾病方面发挥着重要作用.
相关概念视频
Proteomics
7.4K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.4K
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K


